United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
NIHR Launches Funding For Strategic Partnerships With Life Sciences Sector
The National Institute for Health and Care Research has unveiled a groundbreaking £45 million funding initiative through Strategic Infrastructure Partnerships, designed to revolutionize healthcare delivery in England. This multi-year research funding vehicle aims to forge powerful collaborations between NIHR infrastructure and the wider health sector, focusing on community-based care models and independent living technologies. Applications are now open for partnerships addressing urgent care demand red
United Kingdom Healthcare
BS
Burges Salmon
Article
Life Sciences Patents Monthly Roundup—September 2026
This September edition examines pivotal developments in life sciences patent law across Europe, with the Unified Patent Court continuing to refine its jurisprudence on added matter, intermediary liability, and procedural standards. National courts in the UK, France, and the Netherlands deliver significant rulings on supplementary protection certificates, pro-drugs, and the boundaries of pharmacy exemptions that will shape patent strategy for pharmaceutical and medical device companies.
European Union IP
AO
A&O Shearman
Article
Spinal Cord Injuries: Emerging Technology Update
Technology aimed at improving independence following spinal cord injury continues to develop, from mobility equipment already on the market to implantable devices that are still at an early stage of research. This article examines three different technologies and considers how developments such as these could shape the lives of people living with SCI, as well as what they might mean for future claims.
United Kingdom Healthcare
W
Weightmans
Article
Liverpool City Region Recognised By WIPO For Fostering Innovation And Creativity
Liverpool has been named as a finalist for the World Intellectual Property Organisation's City of Innovation award, recognising the city's commitment to fostering innovation and creativity. The city region demonstrates particular strengths in life sciences, digital technologies, and advanced manufacturing, with support from organisations like Sci-Tech Daresbury and Knowledge Quarter Liverpool's KQ CLICK business support program.
United Kingdom IP
MC
Marks & Clerk
Article
How Low Can You Go? T 0137/24, Percentage Sequence Identity Claims And Divergent EPO And USPTO Approaches
The European Patent Office Board of Appeal's decision in T 0137/24 examines whether increasing percentage sequence identity thresholds in patent claims constitutes added matter and whether such claims meet sufficiency requirements. This case highlights the divergent approaches between European and US patent offices when evaluating biotechnology claims that define protein variants through sequence identity percentages combined with functional limitations.
United Kingdom IP
HL
HGF Ltd
Podcast
(Medical) Crimes And (Data) Misdemeanours - Writing To The European Commission’s AI Act Service Desk Concerning Annex V Of The EU AI Act (Conformity Assessments) - LIVE! (Podcast)
Marc Dautlich and Alex Denoon explore the complexities of the EU AI Act's Declaration of Conformity requirements, specifically examining what it means for High-Risk AI Systems to comply with GDPR. The podcast addresses the practical challenges providers face when preparing this living document for AI-integrated medical devices and other regulated systems.
United Kingdom Healthcare
B
Bristows
Article
Global Life Sciences & Healthcare Bulletin
Eversheds Sutherland provides legal insights and analysis through their Global Life Sciences and Healthcare Bulletin series. The firm's international team of attorneys offers guidance on regulatory developments, compliance matters, and strategic considerations affecting pharmaceutical, biotechnology, and healthcare organizations. Contact their specialized practitioners for detailed counsel on navigating complex legal frameworks in the life sciences sector.
Global Healthcare
ES
Eversheds Sutherland
Article
Gene-edited "Sunshine" Tomato Receives First Marketing Approval In England
The UK has approved a marketing notice for the "Sunshine" tomato, a gene-edited variety engineered to contain elevated levels of provitamin D3. This milestone marks the first precision-bred tomato to receive approval under England's post-Brexit regulatory framework, bringing a new dietary source of vitamin D closer to commercialisation while demonstrating the practical implementation of the Genetic Technology (Precision Breeding) Act 2023.
United Kingdom Healthcare
MC
Marks & Clerk
Article
The EU Pharma Package: Upcoming Reform Of Regulatory Data Exclusivity And Market Protection For Approved Medicines For Human Use
The European Parliament and Council have agreed on the most significant reform of EU pharmaceutical legislation in two decades, fundamentally restructuring the regulatory data exclusivity and market protection framework for newly approved medicines. While the baseline eight-year data protection period remains unchanged, the market exclusivity system has been overhauled with a new modulated approach that reduces automatic protection and requires pharmaceutical companies to complete specific clinical studies
European Union Healthcare
PS
Penningtons Manches Cooper LLP
Article
Sustainable Fertilisers: Innovations, Patentability, And Start-Up Support In Europe
Geopolitical conflicts and climate change are threatening global food security by disrupting fertiliser supply chains and driving up costs. European companies are developing innovative solutions ranging from green ammonia production and nitrogen fixation technologies to circular fertilisers derived from waste streams and biological alternatives that enhance nutrient efficiency.
European Union IP
HL
HGF Ltd
Article
Advancing Advanced Manufacturing Capabilities In Glasgow
Glasgow's XWORKS innovation hub represents a £11 million investment in advanced manufacturing infrastructure, set to provide 45,000 sq ft of flexible workspace for mid-tech companies in clean energy, defence, space and life sciences sectors. The facility, scheduled for completion in early 2027, aims to lift technological limitations for innovators and start-ups while strengthening Glasgow's position as a destination for innovation-led businesses.
United Kingdom Real Estate
MC
Marks & Clerk
Article
HPV-positive Oropharyngeal Cancer: Prevention To Precision Treatment
Human papillomavirus vaccination has dramatically reduced cervical cancer rates in young women across the EU, but could the same approach work for HPV-positive oropharyngeal cancer, which has tripled in incidence among Scandinavian men over three decades? As gender-neutral vaccination programs roll out and immunotherapy strategies evolve, the landscape for treating and potentially preventing HPV-driven head and neck cancers is undergoing a fundamental transformation.
Global Healthcare
PC
Potter Clarkson
Article
Virtual And Digital Health Digest – July 2026
European regulators are accelerating AI governance frameworks while balancing innovation with patient safety in digital health. The European Commission has published voluntary codes for AI-generated content marking and appointed expert bodies to enforce the AI Act, while the UK's MHRA launches regulatory sandboxes to test AI tools in medicines development and the ICO establishes comprehensive guidance for AI-powered healthcare technologies.
United Kingdom Healthcare
AP
Arnold & Porter
See more

Latest Videos

See more